会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明申请
    • NOVEL DAMMARANE SAPOGENINS, THEIR USE AS ANTI-CANCER AGENTS, AND A PROCESS FOR PRODUCING SAME
    • 新型丹麦青蒿素,其作为抗癌剂的用途及其生产方法
    • WO2003010182A1
    • 2003-02-06
    • PCT/CA2002/001173
    • 2002-07-24
    • PANAGIN PHARMACEUTICALS INC.HUANG, DongQI, Dong, Feng
    • HUANG, DongQI, Dong, Feng
    • C07J17/00
    • C07J17/005
    • This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarane sapogenin structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarane sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and/or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
    • 本发明涉及一组新的皂甙元,它们在抗癌应用中的用途,以及它们的制备方法。 更具体地说,本发明涉及一组新的一组抗坏血酸皂苷元PAM-120,PBM-110和PBM-100(在任何位置上任何糖部分(糖)和C-20处的羟基) 和PAN-20和PAN-30(dammarane sapogenin结构具有糖部分,但在C-20时不含羟基),通过化学裂解dammarane皂苷获得。 本发明还包括通过分别或一起使用它们,和/或与其它药物联合使用所述皂苷元进行抗癌治疗的新应用,以及生产这些新型皂甙元的方法。 所述新型的dammarane sapogenins在使用时显示出惊人的抗癌作用,特别是针对多重耐药性癌症。